Drug Profile
Research programme: CNS disorder therapies - sigma-tau
Alternative Names: ST 1859; ST 1936; ST 2472Latest Information Update: 16 Jul 2016
Price :
$50
*
At a glance
- Originator sigma-tau SpA
- Class
- Mechanism of Action Undefined mechanism
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
Highest Development Phases
- No development reported Alzheimer's disease; Depressive disorders; Schizophrenia
Most Recent Events
- 16 Jul 2016 No recent reports of development identified for preclinical development in Alzheimer's-disease in Italy
- 16 Jul 2016 No recent reports of development identified for preclinical development in Depressive disorders in Italy
- 16 Jul 2016 No recent reports of development identified for preclinical development in Schizophrenia in Italy